CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review 2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization) Systemic microvascular dysfunction in microvascular and vasospastic angina Know Diabetes by Heart: A Partnership to Improve Cardiovascular Outcomes in Type 2 Diabetes Mellitus Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention

Guideline2016 Jan 14;37(3):267-315.

JOURNAL:Eur Heart J. Article Link

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)

Roffi M, Patrono C, ESC Scientific Document Group. Keywords: Acute cardiac care; Acute coronary syndromes; Angioplasty; Anticoagulation; Apixaban; Aspirin; Atherothrombosis; Beta-blockers; Bivalirudin; Bypass surgery; Cangrelor; Chest pain unit; Clopidogrel; Dabigatran; Diabetes; Early invasive strategy; Enoxaparin; European Society of Cardiology; Fondaparinux; Glycoprotein IIb/IIIa inhibitors; Guidelines; Heparin; High-sensitivity troponin; Myocardial ischaemia; Nitrates; Non-ST-elevation myocardial infarction; Platelet inhibition; Prasugrel; Recommendations; Revascularization; Rhythm monitoring; Rivaroxaban; Statin; Stent; Ticagrelor; Unstable angina; Vorapaxar

FULL TEXT PDF